INFORMAZIONI SU QUESTO EPISODIO
touchCONGRESS for touchONCOLOGY
Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly.
We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Eli Lilly. This activity is provided by touchIME.
For further information visit our website: https://touchoncologyime.org/hrher2-breastcanceresmo2020touchcongress/
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di touchPODCAST.
ALTRI EPISODI IN QUESTO PODCAST
touchPANEL DISCUSSION for touchNEUROLOGY
Hear from three experts as they share practical insights into recognizing and diagnosing Lennox–Gastaut syndrome across the lifespan, navigating the complexities of polytherapy, and addressing the cognitive, behavioral, functional, and quality of life chall…
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss the medical and surgical decision-making challenges in perineal and genital HS, including common diagnostic pitfalls, how to integrate medical and surgical treatment, and the unique role of urology in managing complex disea…
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to an interview with Dr. Christine Kay on the role of vitamin A in the retina, how vitamin A processing is disrupted in Stargardt disease, and the mechanism of action, emerging clinical evidence, and key safety considerations for emerging oral therap…
touchIN CONVERSATION for touchNEUROLOGY and touchONCOLOGY
Management of neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas in adults requires individualized decisions that account for symptoms, function, resectability and patient goals. Listen to NF1 experts Prof. Allan Belzberg, a …
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.
The multidisciplinary team
Dr. Melinda …
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da touchpodcast, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
